About NanoPharmaceuticals
NanoPharmaceuticals is a private company based in Troy, New York. It has reported $6,573,215 raised in four offerings on Form D since February 2014.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 23, 2025 | Feb 4, 2025 | $622,500of $2.4M target | 12 | $51,875 | EquityRule 506(b) | Form D ↗ |
| Aug 6, 2018 | Aug 20, 2018 | $1,332,240target not set | 8 | $166K | EquityRule 506(b) | Form D ↗ |
| Apr 12, 2017 | Apr 24, 2017 | $1,995,975target not set | 16 | $124K | EquityRule 506(b) | Form D ↗ |
| Nov 15, 2013 | Feb 3, 2014 | $2,622,500target not set | 13 | $201K | EquityRule 506(b) | Form D ↗ |
| Total, four offerings | $6,573,215 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on NanoPharmaceuticals's Form D filed Feb 4, 2025.
PD
Paul Davis
Director
EM
Eliza McKinney
Vice President
CW
Carl Walkey
Executive officer
SM
Shaker Mousa
Director
Earlier filings also listed T. Dewey (director, last listed Aug 2018), Michael Rosenthal (chief executive officer and director, last listed Aug 2018), Eliza Parker (executive officer, last listed Aug 2018) and James Gozzo (executive officer and director, last listed Feb 2014).